⌘K

Login Start Free

Home/Filings/4/0000891293-20-000046

4//SEC Filing

SEELEY BRUCE J. 4

Accession 0000891293-20-000046

CIK 0000891293other

View on SEC.gov Company Profile

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 5:22 PM ET

Size

4.6 KB

Accession

0000891293-20-000046

Insider Transaction Report

Form 4

Period: 2020-06-30

CTI BIOPHARMA CORPctic

SEELEY BRUCE J.

EVP, Chief Commercial Officer

Transactions

Award
Common Stock
2020-06-30$0.99/sh+500$493→ 32,500 total

Footnotes (1)

[F1]Shares acquired under the CTI BioPharma Corp. 2007 Employee Stock Purchase Plan.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

CTI BIOPHARMA CORP

CIK 0000891293

Entity typeother

Related Parties

1

filerCIK 0001474462

Filing Metadata

Form type: 4
Filed: Jul 1, 8:00 PM ET
Accepted: Jul 2, 5:22 PM ET
Size: 4.6 KB

View on SEC.gov